Category WTO/TRIPS

WTO: Wide Support For LDC TRIPS Extension, With A Hitch

The World Trade Organization committee on intellectual property rights met this week and addressed a request by least developed countries for an extension of the period to enforce WTO intellectual property rules. LDCs want that the extension be extinguishable only after a country ceases to be considered as 'least developed', which developing countries largely supported. Developed countries, however, were hesitant about the terms of the proposed extension.

India’s First Compulsory Licence Upheld, But Legal Fights Likely To Continue

New Delhi - India’s Intellectual Property Appellate Board (IPAB) today upheld the country’s first compulsory licence on a pharmaceutical product. The much-awaited verdict by Justice (Ms) Prabha Sridevan upholds the compulsory licence issued to Hyderabad-based Natco Pharma Ltd, an Indian generic drug manufacturer, which sells a much cheaper version of German pharmaceutical company Bayer AG's kidney and liver cancer drug Nexavar in the market.

Should Industry Support LDCs’ Request For Unlimited Time To Implement The TRIPS Agreement? Absolutely

Nick Ashton-Hart writes: Some of you may have noticed that the ICT sector trade association that I represent in Geneva, the Computer and Communication Industry Association (CCIA), has endorsed a bid by the world’s Least Developed Countries (LDC’s) to remove any specific deadline for full compliance with the Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement.

WTO: LDCs To Press For Extension For TRIPS, Plain Packaging Back

Least developed countries next week will ask that World Trade Organization members grant them another extension of the transition period to enforce intellectual property protection measures beyond the current date of 1 July 2013. In addition, the issues of plain packaging for tobacco products and innovation will be back on the agenda of the WTO intellectual property committee.

Letter Shows US Pressure On Global Fund For Compulsory Licensing, Generics

A 2011 letter from the top Republican on the United States Senate Finance Committee condemned efforts by the Global Fund to train public health officials on the use of flexibilities to the patent system contained in international trade rules. The letter, which also attacked the purchase of generic medicines over brand-name drugs, came just months before the US helped remove the head of the Global Fund, ultimately replacing him with an American official.

Tracking IP Influencers’ Latest Moves

From changes in policymaking leadership and staffing shake-ups to a flurry of hiring in law firms and new strategic alliances, the past few months have been an interesting time for IP people watching. With over 40 news items and over 80 names, here’s a substantial update on who’s who across governments, nonprofit organisations, and the private sector.

WTO: Antigua To Retaliate Against US By Suspending IP Rights Protection

After years of unsuccessful negotiations between nations, the World Trade Organization Dispute Settlement Body today gave Antigua and Barbuda the right to impose sanctions against the United States for blocking online gambling. The US was found in violation of WTO rules in 2007 and has failed to resolve the issue, so the Caribbean nation was given the right to retaliate in an area that is likely to force a US response - lifting US intellectual property rights.

IP-Watch Looks At The Year Ahead In International IP Policy

What will 2013 bring for international intellectual property and innovation policy?

In the coming Intellectual Property Watch series for subscribers, our expert writers take a look at the top global policy issues and events in copyright, public health, legal battles, food security/biotech/biodiversity, trade, development, internet governance and more.